Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welch

Showing results (371-380 of 422) with videos related to

Pageof 43
Sort By:
NPJ Precision Oncology|August 5, 2024
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunitiesAriane Lozac'hmeur, Tyler Danek, Qidi Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumoursA F Leary, M Quinn, K Fujiwara, et al.
Trends in Ecology & Evolution|May 18, 2020
Analogies for a No-Analog World: Tackling Uncertainties in Reintroduction PlanningElizabethS Forbes, Peter S Alagona, Andrea J Adams, et al.
Plos Computational Biology|August 8, 2014
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionChristopher A Miller, Brian S White, Nathan D Dees, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspectiveA M Oza, V Castonguay, D Tsoref, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharingE R Malone, R R Saleh, C Yu, et al.
Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.
Nature|October 18, 2013
Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D McLellan, Fabio Vandin, et al.
Pageof 43

Showing results (371-380 of 422) with videos related to

Sort By:
Pageof 43
NPJ Precision Oncology|August 5, 2024
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunitiesAriane Lozac'hmeur, Tyler Danek, Qidi Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumoursA F Leary, M Quinn, K Fujiwara, et al.
Trends in Ecology & Evolution|May 18, 2020
Analogies for a No-Analog World: Tackling Uncertainties in Reintroduction PlanningElizabethS Forbes, Peter S Alagona, Andrea J Adams, et al.
Plos Computational Biology|August 8, 2014
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionChristopher A Miller, Brian S White, Nathan D Dees, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspectiveA M Oza, V Castonguay, D Tsoref, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharingE R Malone, R R Saleh, C Yu, et al.
Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.
Nature|October 18, 2013
Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D McLellan, Fabio Vandin, et al.
Pageof 43